Abstract
AbstractEmerging technologies have brought a drastic change in the field of pharmaceutical development, as well as in manufacturing strategies. Pharma 4.0 is the revolution in the pharmaceutical sector dealing with automation and integration of the complete supply chain in an industry. Pharmaceutical manufacturing issues have the potential to cause significant influence on patient healthcare, as breaches in required quality can result in product recalls and patient injury. Moreover, product failures, facility, materials, or manufacturing issues are vital factors leading to disruptions in pharmaceutical supply chain. This research study makes an attempt to assess the barriers in implementation of Industry 4.0 in pharmaceutical industries using Interpretive Structural Modeling (ISM) and Analytic Hierarchy Process (AHP) methods. Solution for mitigating the barriers is proposed in the paper.KeywordsPharma 4.0Interpretive structural modeling (ISM)Analytic hierarchy process (AHP)Industry 4.0
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
